184 related articles for article (PubMed ID: 28244178)
1. Evaluation of an optimized [
Caminiti SP; Alongi P; Majno L; Volontè MA; Cerami C; Gianolli L; Comi G; Perani D
Eur J Neurol; 2017 May; 24(5):687-e26. PubMed ID: 28244178
[TBL] [Abstract][Full Text] [Related]
2. A disease-specific metabolic brain network associated with corticobasal degeneration.
Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
[TBL] [Abstract][Full Text] [Related]
3. FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice.
Arnone A; Allocca M; Di Dato R; Puccini G; Laghai I; Rubino F; Nerattini M; Ramat S; Lombardi G; Ferrari C; Bessi V; Sorbi S; De Cristofaro MT; Polito C; Berti V
Neurol Sci; 2022 Sep; 43(9):5333-5341. PubMed ID: 35697965
[TBL] [Abstract][Full Text] [Related]
4. PET Molecular Imaging in Atypical Parkinsonism.
Xu Z; Arbizu J; Pavese N
Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
[TBL] [Abstract][Full Text] [Related]
5. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.
Tripathi M; Dhawan V; Peng S; Kushwaha S; Batla A; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
Neuroradiology; 2013 Mar; 55(4):483-92. PubMed ID: 23314836
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
[TBL] [Abstract][Full Text] [Related]
8. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
9. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
10. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
11. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
[TBL] [Abstract][Full Text] [Related]
12. Validation of
Presotto L; Ballarini T; Caminiti SP; Bettinardi V; Gianolli L; Perani D
Neuroinformatics; 2017 Apr; 15(2):151-163. PubMed ID: 28063108
[No Abstract] [Full Text] [Related]
13. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
Perani D; Della Rosa PA; Cerami C; Gallivanone F; Fallanca F; Vanoli EG; Panzacchi A; Nobili F; Pappatà S; Marcone A; Garibotto V; Castiglioni I; Magnani G; Cappa SF; Gianolli L;
Neuroimage Clin; 2014; 6():445-54. PubMed ID: 25389519
[TBL] [Abstract][Full Text] [Related]
14. SPECT Molecular Imaging in Atypical Parkinsonism.
Brumberg J; Isaias IU
Int Rev Neurobiol; 2018; 142():37-65. PubMed ID: 30409259
[TBL] [Abstract][Full Text] [Related]
15. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
16. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.
Juh R; Pae CU; Kim TS; Lee CU; Choe B; Suh T
Neurosci Lett; 2005 Jul 22-29; 383(1-2):22-7. PubMed ID: 15936506
[TBL] [Abstract][Full Text] [Related]
17. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
[TBL] [Abstract][Full Text] [Related]
18. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
19. Typical cerebral metabolic patterns in neurodegenerative brain diseases.
Teune LK; Bartels AL; de Jong BM; Willemsen AT; Eshuis SA; de Vries JJ; van Oostrom JC; Leenders KL
Mov Disord; 2010 Oct; 25(14):2395-404. PubMed ID: 20669302
[TBL] [Abstract][Full Text] [Related]
20. FDG PET in the differential diagnosis of parkinsonian disorders.
Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
